Generic apixaban tablet tested against eliquis in healthy volunteers
NCT ID NCT06043297
First seen Jun 26, 2026 · Last updated Jun 26, 2026
Summary
This study tested whether a generic version of the blood thinner apixaban (5mg tablet) works the same as the brand-name drug Eliquis. Thirty healthy adults took a single dose of each under fasting conditions, and researchers measured drug levels in their blood. The goal was to check if the two products are bioequivalent, meaning they deliver the same amount of medicine into the body.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
- Active substance
- apixaban 5mg tablet
- What this could lead to
- If successful, this could show that the generic apixaban tablet is equivalent to the brand-name drug, potentially offering a more affordable option for patients needing blood thinning.
- What could go wrong
- This is a small, early-phase study in 30 healthy volunteers, not patients. It only measures drug levels in the blood, not actual health outcomes, so results may not predict real-world effectiveness or safety.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for ANTITHROMBIC DRUG are added.
By submitting, you agree to our Terms of use
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
Lambda Therapeutic Research Ltd.
Ahmedabad, Gujarat, 382481, India